York Michael
Insider CIK 1755422 · PHAS VP, Corporate Development · MTCR Chief Business Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MTCR Metacrine, Inc. | S Sale | 2023-01-26 | 2023-01-27 | 107,054 | $0.41 | $43.9K | 103,499 | SEC↗ |
| MTCR Metacrine, Inc. | A Award deriv | 2022-02-27 | 2022-03-01 | 210,553 | — | $0 | 210,553 | SEC↗ |
| MTCR Metacrine, Inc. | A Award | 2022-02-27 | 2022-03-01 | 210,553 | — | $0 | 210,553 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award | 2021-05-20 | 2021-05-24 | 2,897 | $2.80 | $8.1K | 7,059 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2021-02-05 | 2021-02-09 | 36,000 | — | $0 | 36,000 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award | 2020-11-20 | 2020-11-23 | 2,662 | $3.00 | $8.0K | 4,162 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2020-02-12 | 2020-02-14 | 55,000 | — | $0 | 55,000 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2019-02-27 | 2019-03-01 | 45,000 | — | $0 | 45,000 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | P Buy | 2018-12-11 | 2018-12-11 | 1,500 | $3.88 | $5.8K | 1,500 | SEC↗ |